Agile Therapeutics Inc logo

Agile Therapeutics Inc

NAS:AGRX (USA)  
$ 0.89 -0.0574 (-6.06%) 10:08 PM EST
At Loss
Volume:
869.05K
Avg Vol (2M):
470.51K
Also Trade In:
Volume:
869.05K
At Loss
Avg Vol (2M):
470.51K

Business Description

Description
Agile Therapeutics Inc is a women's healthcare company to fulfill the unmet health needs of women. Its product candidates are designed to provide women with contraceptive options. The firm's initial product, Twirla, (levonorgestrel and ethinyl estradiol) transdermal system is a non-daily prescription contraceptive. Twirla is based on proprietary transdermal patch technology, called Skinfusion, which is designed to allow drug delivery through the skin. The Company views its operations and manages its business in one operating and reporting segment, which is the business of commercializing its transdermal patch for use in contraception.
Name Current Vs Industry Vs History
Cash-To-Debt 1.14
Equity-to-Asset -1.14
Debt-to-Equity -0.2
Debt-to-EBITDA -0.21
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -56.51
Distress
Grey
Safe
Beneish M-Score -8.72
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 57
3-Year EPS without NRI Growth Rate 51.4
3-Year FCF Growth Rate 49.1
Name Current Vs Industry Vs History
5-Day RSI 7.74
9-Day RSI 15.7
14-Day RSI 22.14
6-1 Month Momentum % -31.28
12-1 Month Momentum % -88.43

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.57
Quick Ratio 0.44
Cash Ratio 0.16
Days Inventory 88.98
Days Sales Outstanding 66.49
Days Payable 311.66

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -190.9
Shareholder Yield % 4.82

Financials (Next Earnings Date:2024-03-30 Est.)

AGRX's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:AGRX

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Agile Therapeutics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 19.974
EPS (TTM) ($) -13.33
Beta 0.81
Volatility % 57.35
14-Day RSI 22.14
14-Day ATR ($) 0.140928
20-Day SMA ($) 1.289105
12-1 Month Momentum % -88.43
52-Week Range ($) 0.78 - 14.5
Shares Outstanding (Mil) 2.96

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Agile Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Agile Therapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Agile Therapeutics Inc Frequently Asked Questions

What is Agile Therapeutics Inc(AGRX)'s stock price today?
The current price of AGRX is $0.89. The 52 week high of AGRX is $14.50 and 52 week low is $0.78.
When is next earnings date of Agile Therapeutics Inc(AGRX)?
The next earnings date of Agile Therapeutics Inc(AGRX) is 2024-03-30 Est..
Does Agile Therapeutics Inc(AGRX) pay dividends? If so, how much?
Agile Therapeutics Inc(AGRX) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1